Первая пятница декабря
Конгресс 2014
Главная / Новости


1 2 3 4 5 6 7 8 9 10

19 августа 2019 - Descemet membrane endothelial keratoplasty (DMEK): an update on safety, efficacy and patient selection
Abstract: Descemet membrane endothelial keratoplasty (DMEK) is gaining popularity worldwide as a procedure to address corneal endothelial dysfunctions. Its perfect anatomical result improves outcomes and expedites visual recovery. This review addresses important aspects of safety, efficacy and patient selection.

18 августа 2019 - Новый номер Новостей глаукомы готовится к печати полным ходом!
Именно в этом номере можно будет прочитать полную программу Конгресса Российского глаукомного общества! Ждем!

13 августа 2019 - New Anterior Segment Anatomy Handout
ANTERION® – the multimodal imaging platform optimized for the anterior segment – provides a high-resolution visualization of the entire anterior segment, from the anterior surface of the cornea to the posterior surface of the lens. ANTERION delivers revealing swept-source OCT images that provide visual confirmation and add reliability to the diagnosis and follow-up of anterior segment alterations.

10 августа 2019 - FDA rejects Kala’s dry eye NDA, requests additional data
The FDA is requiring Kala Pharmaceuticals to complete an additional clinical trial of KPI-121 0.25%, its candidate for the temporary relief of dry eye signs and symptoms, according to a press release.

28 июля 2019 - Surgery-induced iris abnormalities after Descemet membrane endothelial keratoplasty and their impact on postoperative clinical outcomes [Letter]
Natsuko Mori,1,2 Hideaki Yokogawa,1 Akira Kobayashi,1 Tsubasa Nishino,1,3 Kazuhisa Sugiyama1 1Department of Ophthalmology, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan; 2Department of Ophthalmology, Saiseikai Kanazawa Hospital, Kanazawa, Japan; 3Department of Ophthalmology, Toyama Prefectural Central Hospital, Toyama, Japan Purpose: This study aimed to elucidate the frequency of surgery-induced iris abnormalities after Descemet membrane endothelial keratoplasty (DMEK) and their impact on postoperative clinical outcomes.

24 июля 2019 - A Clearer Focus: Moving Forward to Improve the Management of Ocular Surface Disease
Ocular surface disease (OSD) encompasses several disorders which include dry eye disease, blepharitis, meibomian gland dysfunction, ocular allergy, and conjunctivitis. Accurate diagnosis of OSD is characteristically challenging, as patients may present with more than one concurrent condition with substantial overlap of signs and symptoms. Therefore, OSD is frequently misdiagnosed and subsequently undertreated. In this CME activity, experts in the field will assess therapeutic strategies for optimal management of OSD as well as the different approaches for monitoring treatment response. The presentation of case studies will further provide tools to integrate treatment and monitoring pearls into practice.

13 июля 2019 - Light on the Horizon. Новинки!
Evidence from randomized controlled trials supports the use of two less invasive glaucoma treatment options, selective laser trabeculoplasty and a microstent. By Chelvin Sng, MBBChir, MA, MMed, FRCS(Ed); and Keith Barton, MD, FRCP, FRCS

10 июля 2019 - Программа конгресса Российского глаукомного общества (6 и 7 декабря готова). Все!
Скоро она будет размещена в сети, и конечно же в бюллетене Новости глаукомы (№4, 2019, осень)

29 июня 2019 - Aptar Pharma’s Preservative-Free Multidose Dispenser Approved for Anti-Allergy Treatment by French Regulatory Agency ANSM
Aptar Pharma’s innovative, preservative-free multidose Ophthalmic Squeeze Dispenser has been announced as the approved delivery device for Bausch+Lomb’s Levofree Multidose in France. This marks the first approval by the French National Agency for Medicines and Health Products Safety (ANSM) for Aptar Pharma’s Ophthalmic Dispenser.

19 июня 2019 - Круглый стол "Актуальные вопросы офтальмологии. Приверженность к лечению больных с глаукомой"
Программа круглого стола "Актуальные вопросы офтальмологии. Приверженность к лечению больных с глаукомой", 20 сентября 2019 года

11 июня 2019 - New Trial Findings Presented for Metastatic Uveal Melanoma Candidate Drug Tebentafusp
Immunocore Limited yesterday presented new biomarker research data for effects of Tebentafusp (IMCgp100) on patients with advanced uveal and cutaneous melanoma. Monotherapy treatment with the first-in-class ImmTAC® molecule tebentafusp was found to induce an immunologically potent response in patients. These findings, presented at the 2019 American Society of Clinical Oncology (ASCO) Annual Meeting, provide additional insight into the mechanism of action of tebentafusp in patients with advanced melanoma and demonstrates the potential association with clinical outcomes.

08 июня 2019 - CLINICAL comparison of speculums influence on intraoperative aberrometry reading
Purpose: The aim of this study was to evaluate the influence of four different types of speculums on aberrometry reading (OPD SCAN III [OPD]) and on intraoperative aberrometry reading (optiwave response analyzer, ORA).

30 мая 2019 - New Concepts in Glaucoma Detection and Treatment
ABSTRACT SUMMARY In this observational case-controlled study, investigators used OCT angiography to evaluate microvascular perfusion in the optic nerve head region of glaucomatous eyes with or without disc hemorrhage (DH). The researchers also studied the relationship between parapapillary choroidal microvascular dropout (MVD) and retinal nerve fiber layer (RNFL) thickness. The study included 82 eyes with open-angle glaucoma (OAG) and DH and 68 OAG eyes without DH, all of which had at least four serial OCT angiography examinations. Outcome measures included MVD detection rate, extent of MVD, and RNFL thinning rate. MVD was defined as complete loss of microvasculature within the choroidal layer of the parapapillary region.

29 мая 2019 - Новый летний номер журнала Клиническая офтальмология вышел! Ждете?
Скоро подписчики его получат! А авторов приглашаем к сотрудничеству!

26 мая 2019 - APAO 2019 – Quantel Medical Symposium SubLiminal Laser for Retinal Disorders: Diabetic Macular Edema
Dr Kenneth Fong (Sunway Medical Center – Malaysia) explains the interest of 577nm SubLiminal laser in the treatment of DME (видео)

22 мая 2019 - Нужно поработать, коллеги!
Приказ Министерства здравоохранения РФ от 28 февраля 2019 г. № 103н "Об утверждении порядка и сроков разработки клинических рекомендаций, их пересмотра, типовой формы клинических рекомендаций и требований к их структуре, составу и научной обоснованности включаемой в клинические рекомендации информации”.

1 2 3 4 5 6 7 8 9 10
Что "заставляет" Вас заниматься научными исследованиями?